Delivery Order SPE2DR25D2009-SPE2DR26FJ3P6
Award Date 11/26/25
Potential Completion Date 11/28/25
Potential Value $6.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,259.26 for REXULTI 0.5 mg tablets (30-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded contract (no set-aside designation) leverages AmerisourceBergen's position as a prime vendor under the DLA Troop Support Medical Indefinite Delivery Contract SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $19,710.72 to AmerisourceBergen Drug Corp for the supply of REXULTI 0.5 mg tablets in a 30-count package. The contract was competitively awarded without set-aside designation on May 27, 2025, with a completion date of May 28, 2025. This delivery order operates under a firm fixed-price arrangement and represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order valued at $23,464.63 to AmerisourceBergen Drug Corp for REXULTI 2 mg tablets (30-count supply) with an ultimate completion date of July 1, 2025. This firm fixed-price, non-set-aside contract represents a single delivery under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,337.61 to AmerisourceBergen Drug Corp for REXULTI 2 mg tablets (30-count) on November 18, 2025, with completion expected by November 19, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,448.30 to AmerisourceBergen Drug Corp for supply of REXULTI 0.5 mg tablets (30-count packages). This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,290.83 to AmerisourceBergen Drug Corp for the supply of REXULTI 0.5 mg tablets (30-count packaging) under a firm fixed price contract. This non-set-aside delivery order, awarded on June 2, 2025, with completion scheduled for June 3, 2025, will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for REXULTI 3 mg tablets (30-count packaging) with a ceiling value of $2,928.63 under a firm fixed price contract type. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025, and was executed without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate...
- The Defense Logistics Agency awarded a $17,818.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for REXULTI 0.5 mg tablets (30-count) on December 10, 2025, with completion scheduled for December 11, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under...
- The Defense Logistics Agency awarded a delivery order valued at $111,754.45 to AmerisourceBergen Drug Corp for the supply of REXULTI 2 mg tablets (30-count units) under a firm fixed price arrangement. The award, issued on July 21, 2025, with completion scheduled for July 22, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,179.29 to AmerisourceBergen Drug Corp for the supply of REXULTI 3 mg tablets (30-count packages) with an ultimate completion date of July 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was issued on July 7, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...